Related Experiment Video
Updated: Sep 12, 2025

Induction and Monitoring of Active Delayed Type Hypersensitivity DTH in Rats
Published on: July 19, 2007
A Delayed Adverse Reaction: Hydralazine-Induced Lupus After Years of Use
Saurav Paudel1, Ayushma Acharya2, Sanjiv Poudel3
1Internal Medicine, Kist Medical College, Kathmandu, NPL.
None:
Drug-induced lupus (DIL) is a rare autoimmune condition triggered by certain medications, most commonly hydralazine and procainamide. DIL can manifest after a few weeks or even after several years of drug exposure. We present a case of a 61-year-old female with hypertension and type 2 diabetes mellitus who developed progressive polyarthritis, myalgia, and fatigue that developed over a year after three years of hydralazine use. Laboratory findings revealed anemia, leukopenia, elevated inflammatory markers, an anti-nuclear antibody (ANA) titer of 1:2560, and anti-histone antibodies of 4.9 units. A false-positive immunoglobulin M (IgM) Lyme antibody complicated the diagnostic workup. Discontinuation of hydralazine and initiation of corticosteroid and methotrexate resulted in resolution after six weeks, confirming the diagnosis of hydralazine-induced lupus.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Thiazide-Class Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Rheumatic Heart Disease I: Introduction
Antihypertensive Drugs: Vasodilators

